Earl Martin Douglas

SVP, General Counsel, Allogene Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Aug 21, 2026

Companies

Allogene Therapeutics, Inc.SVP, General Counsel −$0.1M

Trades

ALLO Sold 29,697 shares at $2.12 $0.1M Aug 21

ALLO Sold 22,900 shares at $1.76 $0.0M Feb 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.